EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Periconceptual Progesterone Use and Hypertensive Disorders of Pregnancy: A Population‐Based Cohort Study

Jessica A Atkinson iD, Richard J Hiscock, Anna Forsythe iD, Hannah G Gordon iD, Jenny Myers iD, Susan P Walker, Beverley J Vollenhoven iD, Stephen Tong iD, Roxanne M Hastie, Anthea C Lindquist

BJOG: An International Journal of Obstetrics & Gynaecology · 05.11.2026

DOI: 10.1111/1471-0528.70355 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 05.11.2026. Verfasst von Jessica A Atkinson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Perinatal Epidemiology Group, Department of Obstetrics, Gynaecology, and Newborn Health, The University of Melbourne, Melbourne, Victoria, Australia. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government Research Training Program Scholarships, National Health and Medical Research Council, Norman Beischer Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate whether periconceptual use of progesterone is associated with an altered risk of new‐onset hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, or superimposed preeclampsia).

Design

Population‐based cohort study using statewide pregnancy and birth data from Victoria, Australia, linked with hospital and medication prescribing data.

Setting

Victoria, Australia (2009–2020). Population Nulliparous women who gave birth between 2009 and 2020 in Victoria, Australia. Women with missing delivery dates, medicine dispensation dates, or who were exposed to progesterone in the second or third trimester were excluded.

Methods

We compared nulliparous women exposed to progesterone in the periconceptual period (6 weeks preconception until the end of the first trimester) with those not exposed to progesterone. Inverse probability‐weighted regression adjustment was used to control for confounding factors and investigate the effect of progesterone on the risk of preeclampsia (including superimposed preeclampsia) and gestational hypertension. Main Outcome Measures Development of preeclampsia or gestational hypertension.

Results

Among 386 475 pregnancies, 5657 (1.5%) women used progesterone in the periconceptual period. Progesterone use was associated with a statistically significant reduction in the risk of any new onset hypertensive disorders of pregnancy (adjusted risk ratio [aRR] 0.81 [95% confidence interval [CI] 0.67, 0.98]; adjusted risk difference [aRD] −1.72% [95% CI −3.21%, −0.24%]). Investigating type of hypertension, we found progesterone use was associated with a 1.69% absolute reduced risk of gestational hypertension (aRR 0.60 [95% CI 0.43, 0.83]; aRD −1.69% [95% CI −2.52%, −0.86%]) but no significant change was observed for preeclampsia (aRR 0.97 [95% CI 0.75, 1.25]; aRD −0.13% [95% CI −1.49%, 1.23%]). Restricting our analyses to pregnancies conceived via assisted reproductive technology only, we found similar results, with a statistically significant reduction in the risk of gestational hypertension (aRR 0.80 [95% CI 0.67, 0.95]; aRD −1.02% [95% CI −1.73%, −0.30%]) but not preeclampsia (aRR 0.96 [95% CI 0.83, 1.11]; aRD −0.25% [95% CI −1.23%, 0.72%]).

Conclusions

Among 386 475 nulliparous women, we found periconceptual progesterone use to be associated with a statistically significant reduction in the risk of gestational hypertension, but not preeclampsia. However, these findings are unlikely to be clinically meaningful.

Schlagwörter

Stichwörter der Autor:innen

gestational hypertensionpregnancy‐induced hypertensionpre‐eclampsiaprogesterone

Autor:innen und Institutionen

  • Perinatal Epidemiology Group, Department of Obstetrics, Gynaecology, and Newborn Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
  • Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, University of Manchester, Manchester, UK.
  • Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
  • Monash IVF, Clayton, Victoria, Australia.

ORCID-Profile: Jessica A Atkinson, Anna Forsythe, Hannah G Gordon, Jenny Myers, Beverley J Vollenhoven, Stephen Tong

Förderung

  • Australian Government Research Training Program Scholarships
  • National Health and Medical Research Council
  • Norman Beischer Medical Research Foundation
  • University of Melbourne

Zitieren

APA

Atkinson, J. A., Hiscock, R. J., Forsythe, A., Gordon, H. G., Myers, J., Walker, S. P., Vollenhoven, B. J., Tong, S., Hastie, R. M., & Lindquist, A. C. (2026). Periconceptual Progesterone Use and Hypertensive Disorders of Pregnancy: A Population‐Based Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.70355

Vancouver

Atkinson JA, Hiscock RJ, Forsythe A, Gordon HG, Myers J, Walker SP, et al. Periconceptual Progesterone Use and Hypertensive Disorders of Pregnancy: A Population‐Based Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.70355

BibTeX
@article{Atkinson2026,
  author = {Atkinson, Jessica A and Hiscock, Richard J and Forsythe, Anna and Gordon, Hannah G and Myers, Jenny and Walker, Susan P and Vollenhoven, Beverley J and Tong, Stephen and Hastie, Roxanne M and Lindquist, Anthea C},
  title = {Periconceptual Progesterone Use and Hypertensive Disorders of Pregnancy: A Population‐Based Cohort Study},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2026},
  doi = {10.1111/1471-0528.70355}
}
Kostenlos starten →